|
KR20100091124A
|
|
Medicinal use of 5-benzylaminosalicylic acid derivative or its salt
|
|
KR20100053027A
|
|
Pharmaceutical composition for preventing and treating pain
|
|
KR20090113424A
|
|
Pharmaceutical composition for preventing and treating reperfusion injury
|
|
KR100852962B1
|
|
Manufacturing method of 2-hydroxy-5-phenylalkylaminobenzoic acid derivatives and their salts
|
|
KR20090037715A
|
|
Pharmaceutical composition having improved bioavailability
|
|
US2007298129A1
|
|
Compounds and compositions for treating neuronal death or neurological dysfunction
|
|
KR20090007581A
|
|
Pharmaceutical composition for treating or preventing degenerative and inflammatory diseases
|
|
KR20090051273A
|
|
Pharmaceutical composition for treating or preventing degenerative and inflammatory diseases
|
|
US2007049565A1
|
|
Combination of cell necrosis inhibitor and lithium for treating neuronal death or neurological dysfunction
|
|
JP2007055999A
|
|
Pharmaceutical preparation for treating neurocyte death or nervous function disorder and concomitant therapy
|
|
KR20070082440A
|
|
A pharmaceutical preparation and combination therapy for treating neuronal death or neurological dysfunction
|
|
CN1738627A
|
|
Method for inhibition of necrosis induced by neurotrophin
|
